The authors of a new review of the drug acetaminophen (paracetamol), sold under the brand names Tylenol and Panadol, called for the immediate end of the use of the drug in infants and children, citing the drug’s association with autism spectrum disorder (ASD).
“Our study shows that acetaminophen would never be approved for pediatric use by today’s regulatory standards,” Dr. William Parker, of WPLab, Inc., who led the research team that conducted the review on acetaminophen and autism, told The Defender.